Citations

Showing 10 of 108152 citations.

Two In Cis Variants—Two Worlds Apart
Lo, Ying‐Chun , Narayan, Rupa , Nardi, Valentina , Lennerz, Jochen K. , Lennerz, Jochen , Lo, Ying-Chun

Mayo Clinic

The Oncologist | August 18, 2021 | Volume: 26 | Issue: 12 | Pages: 997-999

10.1002/onco.13946 | PMID 34407276 Get It

Abstract Precision oncology emphasizes genotyping as one of the mainstays of oncological decision-making. The core information element exchanged between the laboratory and the oncologist is the precise mutation. Specifically, it is the written representation typically in the form of a variant description at the DNA or protein level. These annotations can be confusing, and many commercial laboratories have abandoned DNA-level annotations. Here we present a complex double-point mutation to illustrate a situation where a formally “correct” reporting nomenclature can obscure clinically relevant and potentially clinically actionable information. Key Points
Prevalence of Malignancy on Contrast-Enhanced Computed Tomography of the Abdomen and Pelvis in Patients With Unexplained, Unintentional Weight Loss
Noblett, Dylan , Kwong, Austin, Corwin, Michael T. , Fananapazir, Ghaneh

Mayo Clinic

Journal of Computer Assisted Tomography | August 18, 2021 | Volume: 45 | Issue: 5 | Pages: 663-668

10.1097/rct.0000000000001217 | PMID 34407062 Get It

Objective The aim of the study was to evaluate the prevalence of malignancy on contrast-enhanced computed tomography (CT) of the abdomen and pelvis in patients with unexplained, unintentional weight loss (UUWL). Methods This is a retrospective review of 999 adult outpatient contrast-enhanced CT of the abdomen and pelvis for UUWL. Patients were stratified into 2 groups: (1) weight loss only (WLO, n = 222) and (2) UUWL with additional symptoms (UUWL+, n = 777). χ2 test was performed to compare malignancy detection rate in the WLO and UUWL+ groups. Results Prevalence of malignancy was 5.3% (95% confidence interval [CI], 4.2%–7.1%; 55 of 999). Prevalence of malignancy in the WLO group was 2.3% (95% CI, 0.7%–5.2%; 5 of 222), lower than the prevalence of 6.2% (95% CI, 4.6%–8.1%; 48 of 777) in the UUWL+ group (P = 0.02). Prevalence of malignancy was lower in patients younger than 60 years in all patients and in the UUWL+ subgroup (P < 0.01 in both cases). Conclusions There is low prevalence of malignancy on contrast-enhanced CT of the abdomen and pelvis in patients with UUWL, particularly in younger patients and those without additional symptoms.
Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers
Arora, Mansi , Abdelrahman, Amro M. , Alva‐Ruiz, Roberto, Leiting, Jennifer L. , Chen, Xianfeng , Usón, Pedro Luiz Serrano , Dumbauld, Chelsae, Baker, Alexander T. , Gamb, Scott I., Egan, Jan B. , Zhou, Yumei , Nagalo, Bolni Marius , Meurice, Nathalie , Eskelinen, Eeva‐Liisa , Braggio, Esteban , Barrett, Michael T. , Buetow, Kenneth H. , Roberts, Lewis R. , Bekaii‐Saab, Tanios , Ahn, Daniel H. , Truty, Mark J. , Bogenberger, James M. , Yonkus, Jennifer, Alva-Ruiz, Roberto, Leiting, Jennifer L , Serrano Uson Junior, Pedro Luiz, Dumbauld, Chelsae R, Salomao, Marcela A, Roberts, Lewis R , Braggio, Esteban , Uson, Pedro L S , Bekaii-Saab, Tanios S , Nagalo, Bolni , Baker, Alexander , Abdelrahman, Amro M , Yonkus, Jennifer A. , Salomao, Marcela , Kosiorek, Heidi , Sonbol, Mohamad Bassam , Mansfield, Aaron S. , Borad, Mitesh J.

Mayo Clinic

Hepatology | August 18, 2021 | Volume: 75 | Issue: 1 | Pages: 43-58

10.1002/hep.32102 | PMID 34407567 Get It

Abstract Background and aims Biliary tract cancers (BTCs) are uncommon, but highly lethal, gastrointestinal malignancies. Gemcitabine/cisplatin is a standard‐of‐care systemic therapy, but has a modest impact on survival and harbors toxicities, including myelosuppression, nephropathy, neuropathy, and ototoxicity. Whereas BTCs are characterized by aberrations activating the cyclinD1/cyclin‐dependent kinase (CDK)4/6/CDK inhibitor 2a/retinoblastoma pathway, clinical use of CDK4/6 inhibitors as monotherapy is limited by lack of validated biomarkers, diffident preclinical efficacy, and development of acquired drug resistance. Emerging studies have explored therapeutic strategies to enhance the antitumor efficacy of CDK4/6 inhibitors by the combination with chemotherapy regimens, but their mechanism of action remains elusive. Approach and results Here, we report in vitro and in vivo synergy in BTC models, showing enhanced efficacy, reduced toxicity, and better survival with a combination comprising gemcitabine/cisplatin and CDK4/6 inhibitors. Furthermore, we demonstrated that abemaciclib monotherapy had only modest efficacy attributable to autophagy‐induced resistance. Notably, triplet therapy was able to potentiate efficacy through elimination of the autophagic flux. Correspondingly, abemaciclib potentiated ribonucleotide reductase catalytic subunit M1 reduction, resulting in sensitization to gemcitabine. Conclusions As such, these data provide robust preclinical mechanistic evidence of synergy between gemcitabine/cisplatin and CDK4/6 inhibitors and delineate a path forward for translation of these findings to preliminary clinical studies in advanced BTC patients.
Tacrolimus-Induced Bradykinesia Secondary to Phenoconversion in an Elderly Post-Bilateral Lung Transplant Patient
Argevani, Lia, Schuh, Michael J. , Crosby, Sheena

Mayo Clinic

The Senior Care Pharmacist | August 18, 2021 | Volume: 36 | Issue: 1 | Pages: 34-41

10.4140/tcp.n.2021.34 | PMID 33384032 Get It

Objective: To report pharmacogenomics post-related bradykinesia secondary to phenoconversion in an elderly post-bilateral lung transplant patient. Summary: The patient was a 68-year-old double lung transplant patient taking the immunosuppressant and CYP3A4/5 substrate tacrolimus concomitantly with 2 CYP3A4/5 inhibitor medications, fluconazole and diltiazem. This drug combination post-dosing resulted in debilitating bradykinesia 1-2 hours after dosing, increasing the risk of falls and possible increased mortality and morbidity risk. Conclusion: Taking tacrolimus in combination with CYP3A4/5 inhibitors may increase neurologic adverse effects resulting in increased fall and associated increased mortality and morbidity risk.
Spectroscopic label-free microscopy of changes in live cell chromatin and biochemical composition in transplantable organoids
Pettinato, Giuseppe , Coughlan, Mark F. , Zhang, Xuejun , Chen, Liming , Khan, Umar , Glyavina, Maria , Sheil, Conor J. , Upputuri, Paul Kumar , Zakharov, Yuri N. , Vitkin, Edward , D’Assoro, Antonino B. , Fisher, Robert A. , Itzkan, Irving, Zhang, Lei , Qiu, Le , Perelman, Lev T. , Upputuri, Paul K

Mayo Clinic

Science Advances | August 18, 2021 | Volume: 7 | Issue: 34 | Pages: No page available

10.1126/sciadv.abj2800 | PMID 34407934 Get It

Formation of transplantable reproducible hiPSC organoids can be aided with real-time label-free intracellular spectroscopy.
Palliative Care: Critical Concepts for the Geropsychiatrist
Lindsey, Jaclyn M. , Shelton, K. Maureen, Beito, Allison H., Lapid, Maria I.

Mayo Clinic

Focus | August 18, 2021 | Volume: 19 | Issue: 3 | Pages: 311-319

10.1176/appi.focus.20210005 | PMID 34690598 Get It

Abnormal body composition in patients with adrenal adenomas
Delivanis, Danae A. , Andrade, Maria D Hurtado, Cortes, Tiffany , Athimulam, Shobana , Khanna, Aakanksha, Atkinson, E. C., McKenzie, Travis J. , Takahashi, Naoki , Moynagh, Michael R., Hurtado Andrade, Maria D, Takahashi, Naoki , Andrade, Maria D Hurtado, Atkinson, Elizabeth, Bancos, Irina

Mayo Clinic

European Journal of Endocrinology | August 18, 2021 | Volume: 185 | Issue: 5 | Pages: 653-662

10.1530/eje-21-0458 | PMID 34406976 Get It

Objective Increased visceral fat and sarcopenia are cardiovascular risk factors that may explain increased cardiovascular morbidity and frailty in patients with adrenal adenomas. Our objective was to compare body composition measurement of patients with adrenal adenomas to referent subjects without adrenal disease. Design Cross-sectional study, 2014–2018. Methods Participants were adults with nonfunctioning adrenal tumor (NFAT), mild autonomous cortisol secretion (MACS), and Cushing syndrome (CS) and age, sex, and BMI 1:1 matched referent subjects without adrenal disorders. Main outcome measures were body composition measurements calculated from abdominal CT imaging. Intra-abdominal adipose tissue and muscle mass measurements were performed at the third lumbar spine level. Results Of 227 patients with adrenal adenomas, 20 were diagnosed with CS, 76 with MACS, and 131 with NFAT. Median age was 56 years (range: 18–89), and 67% were women. When compared to referent subjects, patients with CS, MACS, and NFAT demonstrated a higher visceral fat (odds ratio (OR): 2.2 (95% CI: 0.9–6.5), 2.0 (1.3–3.2), and 1.8 (1.2–2.7) and a lower skeletal muscle area (OR: 0.01 (95% CI: 0–0.09), 0.31 (0.18–0.49), and 0.3 (1.2–2.7)) respectively. For every 1 µg/dL cortisol increase after overnight dexamethasone, visceral fat/muscle area ratio increased by 2.3 ( P = 0.02) and mean total skeletal muscle area decreased by 2.2 cm 2 ( P = 0.03). Conclusion Patients with adrenal adenomas demonstrate a lower muscle mass and a higher proportion of visceral fat when compared to referent subjects, including patients with NFAT. Even a subtle abnormality in cortisol secretion may impact health of patients with adenomas.
Structural aberrations of the brain associated with migraine: A narrative review
Kim, Sookyoung , Nikolova, Simona , Schwedt, Todd J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | August 18, 2021 | Volume: 61 | Issue: 8 | Pages: 1159-1179

10.1111/head.14189 | PMID 34407215 Get It

Abstract Objective To summarize major results from imaging studies investigating brain structure in migraine. Background Neuroimaging studies, using several different imaging and analysis techniques, have demonstrated aberrations in brain structure associated with migraine. This narrative review summarizes key imaging findings and relates imaging findings with clinical features of migraine. Methods We searched PubMed for English language articles using the key words “neuroimaging” AND/OR “MRI” combined with “migraine” through August 20, 2020. The titles and abstracts of resulting articles were reviewed for their possible inclusion in this manuscript, followed by examination of the full texts and reference lists of relevant articles. Results Migraine is associated with structural brain aberrations within regions that participate in pain processing, the processing of other sensory stimuli, multisensory integration, and in white matter fiber tracts. Furthermore, migraine is associated with magnetic resonance imaging T2/fluid‐attenuated inversion recovery white matter hyperintensities. Some structural aberrations are correlated with the severity and clinical features of migraine, whereas others are not. These findings suggest that some structural abnormalities are associated with or amplified by recurrent migraine attacks, whereas others are intrinsic to the migraine brain. Conclusions Migraine is associated with aberrant brain structure. Structural neuroimaging studies contribute to understanding migraine pathophysiology and identification of brain regions associated with migraine and its individual symptoms. Additional work is needed to determine the extent to which structural aberrations are a result of recurrent migraine attacks, and perhaps reversible with effective treatment or migraine resolution, versus being intrinsic traits of the migraine brain.
Early Gender Differences in Pain and Functional Recovery Following Thoracolumbar Spinal Arthrodesis
Gulbrandsen, Matthew T. , Lara, Nina , Chung, Andrew S. , Crandall, Dennis G. , Chung, Andrew , Crandall, Dennis, Beauchamp, James A. , Chang, Michael

Mayo Clinic

Journal of Clinical Medicine | August 18, 2021 | Volume: 10 | Issue: 16 | Pages: 3654

10.3390/jcm10163654 | PMID 34441952 Get It

Background: To analyze gender differences regarding the recovery experience (pain, function, complications) after spinal arthrodesis surgery. Methods: Pre-operative and post-operative gender-based differences in patient-reported outcomes for open posterior spinal arthrodesis at 6 weeks, 3 months, 6 months, and 1 year were studied, including age, comorbidities, body mass index (BMI), diagnosis, number of vertebrae fused, type of surgery, primary vs. revision surgery, and complications. Statistical analysis included the use of Student’s t-test, Chi square, linear regression, Mann–Whitney U test, and Spearman’s rho. Results: Primary or revision posterior arthrodesis was performed on 1931 consecutive adults (1219 females, 712 males) for deformity and degenerative pathologies. At surgery, females were older than males (61.7 years vs. 59.7 years, p < 0.01), had slightly more comorbidities (1.75 vs. 1.5, p < 0.01), and were more likely to undergo deformity correction (38% vs. 22%, p < 0.01). Females described more pre-op pain (female VAS = 6.54 vs. male VAS = 6.41, p < 0.01) and lower pre-op function (female ODI = 49.73 vs. male ODI = 46.52, p < 0.01). By 3 months post-op, there was no significant gender difference in VAS or ODI scores. Similar pain and function scores between males and females continued through 6 months and 12 months. Conclusion: Although females have more pain and dysfunction before undergoing spinal surgery, the differences in these values do not reach the Minimum Clinically Important Difference (MCID). Post-operatively, there is no difference in pain and function scores among males and females at 3, 6, and 12 months.
Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction
Wan, Siu‐Hin , Slusser, Joshua P. , Burnett, John C. , Hodge, David O. , Chen, Horng H. , McKie, Paul M.

Mayo Clinic

Physiological Reports | August 18, 2021 | Volume: 9 | Issue: 16 | Pages: No page available

10.14814/phy2.14974 | PMID 34405565 Get It